[1]Tsai YC,Chen SH,Lin LC,et al. Anti-inflammatory principles from sarcandra glabra[J]. J Agric Food Chem, 2017, 65(31): 6497-6505.
[2]朱晓莹,李韬,李盛毅,等. 肿节风复方含药血清对肝癌HepG2细胞增殖、端粒酶及凋亡的影响[J].中国实验方剂学杂志, 2014, 20(2): 109-112.
[3]Chou ST, Peng HY, Chang CT,et al. Zanthoxylum ailanthoides Sieb and Zucc. extract inhibits growth and induces cell death through G2/M-phase arrest and activation of apoptotic signals in colo 205 human colon adenocarcinoma cells[J]. Anticancer Res, 2011, 31(5): 1667-1676.
[4]Yamazaki T, Tokiwa T. Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells[J]. Biol Pharm Bull, 2010, 33(10): 1716-1722.
[5]石建伟,唐智柳,蔡美玉,等. 2008~2012年我国女性乳腺癌流行状况的系统性综述[J]. 中国妇幼保健, 2014, 29(10): 1622-1626.
[6]Neophytou C,Boutsikos P, Papageorgis P. Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis[J]. Front Oncol, 2018, 8: 31.
[7]Al-Hajj M,Clarke MF. Self-renewal and solid tumor stem cells[J]. Oncogene, 2004, 23(43): 7274-7282.
[8]Mohammadpour F, Ostad SN, Aliebrahimi S,et al. Anti-invasion effects of cannabinoids agonist and antagonist on human breast cancer stem cells[J]. Iran J Pharm Res, 2017, 16(4): 1479-1486.
[9]蔡加琴,魏晓霞,黄旭慧,等. 氧化苦参碱通过调控上皮间质转化抑制三阴性乳腺癌细胞侵袭转移[J]. 中国临床药理学与治疗学, 2018, 23(1): 13-17.
[10]Fan P,Fan S,Wang H,et al. Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway[J]. Stem Cell Res Ther, 2013, 4(6): 146.
[11]Zhou QM, Sun Y, Lu YY,et al. Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis[J]. Cancer Cell Int, 2017, 17: 84.
[12]李学农. 草珊瑚醇提物抗肿瘤有效部位的HPLC分离及各分离组分体外抗肿瘤作用的实验研究[J]. 海峡药学, 2013, 25(8): 184-185.
[13]Qu Y,Lin Q,Yuan Y,et al. Cyclosporin A inhibits adipogenic differentiation and regulates immunomodulatory functions of murine mesenchymal stem cells[J]. Biochem Biophys Res Commun, 2018, 498(3): 516-522.
[14]周齐. 百里醌抑制体外骨肉瘤细胞转移的实验研究[J]. 中国医学创新, 2016, 13(5): 26-29.
[15]Hu Y,Yague E, Zhao J,et al. Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer[J]. Cancer Lett, 2018, 423: 47-59.
[16]Shen P, Wang HG, Li MM,et al. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells[J]. Biomed Pharmacother, 2017, 92: 78-85. |